(Q45744128)

15 December 2017

title

A randomised trial of enteric-coated nutrient pellets to stimulate gastrointestinal peptide release and lower glycaemia in type 2 diabetes (English)

1 reference

15 December 2017

1 reference

5

1 reference

15 December 2017

author name string

J Ma

1

1 reference

15 December 2017

H L Checklin

2

1 reference

15 December 2017

J M Wishart

3

1 reference

15 December 2017

J E Stevens

4

1 reference

15 December 2017

M Horowitz

6

1 reference

15 December 2017

J H Meyer

7

1 reference

15 December 2017

C K Rayner

8

1 reference

15 December 2017

publication date

8 March 2013

1 reference

15 December 2017

published in

Diabetologia

1 reference

15 December 2017

volume

56

1 reference

15 December 2017

issue

6

1 reference

15 December 2017

page(s)

1236-1242

1 reference

15 December 2017

https://scigraph.springernature.com/pub.10.1007/s00125-013-2876-2

exact match

0 references

cites work

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Intensive glucose control and macrovascular outcomes in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Contributions of basal and postprandial hyperglycemia over a wide range of A1C levels before and after treatment intensification in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Relationships of upper gastrointestinal motor and sensory function with glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Preserved inhibitory potency of GLP-1 on glucagon secretion in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Postcibal gastric emptying of pancreatin pellets: effects of dose and meal oil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effects of intravenous glucagon-like peptide-1 on gastric emptying and intragastric distribution in healthy subjects: relationships with postprandial glycemic and insulinemic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

The separate and combined impact of the intestinal hormones, GIP, GLP-1, and GLP-2, on glucagon secretion in type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effect of intraportal glucagon-like peptide-1 on glucose metabolism in conscious dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Localization and Activation of Glucagon-Like Peptide-2 Receptors on Vagal Afferents in the Rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00125-013-2876-2

Effects of metformin on glucagon-like peptide-1 levels in obese patients with and without Type 2 diabetes.

21 January 2018

1 reference

12 December 2020

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

1 reference

12 December 2020

Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels

1 reference

12 December 2020

Inhibition of gastric emptying by sodium oleate depends on length of intestine exposed to nutrient

1 reference

12 December 2020

Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient

1 reference

12 December 2020

Effect of fatty acid chain length on suppression of ghrelin and stimulation of PYY, GLP-2 and PP secretion in healthy men

1 reference

12 December 2020

Neural mechanisms in the control of blood glucose concentration

1 reference

12 December 2020

Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon

1 reference

12 December 2020

Diagnosis and management of diabetic autonomic neuropathy

1 reference

12 December 2020

Colonic drug targeting

1 reference

12 December 2020

Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes

1 reference

12 December 2020

Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus

1 reference

12 December 2020

Radioimmunoassay of gastric inhibitory polypeptide in plasma

1 reference

12 December 2020

The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed

1 reference

12 December 2020

NEW INTERPRETATION OF ORAL GLUCOSE TOLERANCE

1 reference

12 December 2020

PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION

1 reference

12 December 2020

10.1007/S00125-013-2876-2

Identifiers

DOI

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017